MarkHLeeMD

Oncology • Greenville, NC

Physician

Join to view full profile

Are you Dr. Lee?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 29 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
600 Moye Blvd
Leo Jenkins Cancer Center
Greenville, NC 27834
Phone+1 252-744-2383

Fax+1 252-744-3565
Is this information wrong?

Summary

Dr. Mark Lee, MD is an oncologist in Greenville, North Carolina. He is currently licensed to practice medicine in New York.

Education & Training

University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1991 - 1994
Cook County Health and Hospitals SystemResidency, Internal Medicine, 1988 - 1991
Yonsei University College of MedicineClass of 1982

Certifications & Licensure

NY State Medical License 1990 - 2019

Publications & Presentations

PubMed

4 citations
HPV vaccination uptake among foreign-born Blacks in the US: insights from the National Health Interview Survey 2013-2017.
Leslie E Cofie, Haley D Tailor, Mi Hwa Lee, Lei Xu> ;Cancer Causes & Control. 2022 Apr 1
29 citations
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia.
Sang Eun Yoon, Yuqin Song, Seok Jin Kim, Dok Hyun Yoon, Tsai Yun Chen, Youngil Koh, Ka Won Kang, Ho Sup Lee, Kevin Tay, Soon Thye Lim, Michelle Poon, Cosphiadi Irawan,...> ;The Lancet Regional Health. Western Pacific. 2021 Mar 22
SU-E-J-67: Evaluation of Breathing Patterns for Respiratory-Gated Radiation Therapy Using Respiration Regularity Index.
Cheong K, Lee M, Kang S, Yoon J, Park S, Hwang T, Kim H, Kim K, Han T, Bae H> ;Med Phys. 2014-06-01
A randomized trial of preemptive therapy for prevention of cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation.
Kim, S.T., Lee, M.H., Kim, S.Y., Kim, S.J., Kim, D.H., Jang, J.H., Kim, K., Kim, W.S., Jung, C.W.> ;Int J Hematol. 2010 Jun
Multiple unrelated chromosomal abnormalities in host cells after cord blood transplantation.
Moon, H., Cho, J., Hur, M., Yun, Y., Han, S., Lee, M.H.> ;J Pediatr Hematol Oncol. 2010 May
Considerations for tissue-engineered and regenerative medicine product development prior to clinical trials in the United States.
Lee, M.H., Arcidiacono, J.A., Bilek, A.M., Wille, J.J., Hamill, C.A., Wonnacott, K.M., Wells, M.A., Oh, S.S.> ;Tissue Eng Part B Rev. 2010-02-01
S-1 monotherapy for the treatment of elderly patients with advanced gastric cancer.
Lim J, Kim J, Yi H, Kim H, Lee M, Kim C> ;J. Clin. Oncol.. 2009-05-20
Mechanically activated integrin switch controls alpha5beta1 function.
Friedland, J.C., Lee, M.H., Boettiger, D.> ;Science. 2009-01-30
Biomimetic carbohydrate substrates of tunable properties using immobilized dextran hydrogels.
Lee, M.H., Boettiger, D., Composto, R.J.> ;Biomacromolecules. 2008 Sep
Adhesion of MC3T3-E1 cells to RGD peptides of different flanking residues: detachment strength and correlation with long-term cellular function.
Lee, M.H., Adams, C.S., Boettiger, D., Degrado, W.F., Shapiro, I.M., Composto, R.J., Ducheyne, P.> ;J Biomed Mater Res A. 2007 Apr
Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
Uhm, J.E., Kim, K., Lim, T.K., Park, B., Park, S., Hong, Y.S., Lee, S.C., Hwang, I.G., Koh, K.C., Lee, M.H., Ahn, J.S., Kim, W.S., Jung, C.W., Kang, W.K.> ;Biol Blood Marrow Transplant. 2007 Apr
Influential factors for the collection of peripheral blood stem cells and engraftment in acute myeloid leukemia patients in first complete remission.
Lee, J.,Lee, M. H.,Park, K. W.,Kang, J. H.,Im, D. H.,Kim, K.,Lee, S. H.,Kim, W. S.,Park, J.,Jung, C. W.,Parka, K.> ;Int J Hematol. 2005 Apr
Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling don...
> ;Biol Blood Marrow Transplant. 2005 Feb
L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60.
Han, S., Kim, K., Hahm, E., Lee, S.J., Surh, Y., Park, H.K., Kim, W.S., Jung, C.W., Lee, M.H., Park, K., Yang, J., Yoon, S., Riordan, N.H., Riordan, H.D., Kimler, B.F....> ;J Cell Biochem. 2004 Oct 1
Docetaxel plus cisplatin as second-line therapy in metastatic or recurrent advanced gastric cancer progressing on 5-fluorouracil-based regimen.
Park, S.H., Kang, W.K., Lee, H.R., Park, J., Lee, K., Lee, S.H., Park, J.O., Kim, K., Kim, W.S., Chung, C.W., Im, Y., Lee, M.H., Park, C.H., Park, K.> ;Am J Clin Oncol. 2004 Oct
Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leuke...
Min, Y.H., Cheong, J., Kim, J.Y., Eom, J.I., Lee, S.T., Hahn, J.S., Ko, Y.W., Lee, M.H.> ;Cancer Res. 2004 Aug 1
Elevated S-phase kinase-associated protein 2 protein expression in acute myelogenous leukemia: its association with constitutive phosphorylation of phosphatase and ten...
Min, Y.H., Cheong, J., Lee, M.H., Kim, J.Y., Lee, S.T., Hahn, J.S., Ko, Y.W.> ;Clin Cancer Res. 2004 Aug 1
Gefitinib (ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancer.
Park, J., Park, B.B., Kim, J.Y., Lee, S., Lee, S.I., Kim, H.Y., Kim, J.H., Park, S.H., Lee, K., Park, J.O., Kim, K., Jung, C.W., Park, Y.S., Im, Y., Kang, W.K., Lee, M...> ;Clin Cancer Res. 2004 Jul 1
Tuberculosis in hematopoietic stem cell transplant recipients in Korea.
Lee, J., Lee, M.H., Kim, W.S., Kim, K., Park, S.H., Lee, S., Lee, K., Park, J., Park, J.O., Jung, C.W., Im, Y., Kang, W.K., Park, K.> ;Int J Hematol. 2004 Feb
Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis.
Hyun Park, W., Hee Cho, Y., Won Jung, C., Oh Park, J., Kim, K., Hyuck Im, Y., Lee, M.H., Ki Kang, W., Park, K.> ;Biochem Biophys Res Commun. 2003 Jan 3
Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.
Kim, K., Lee, M.H., Kim, J., Lee, K.S., Kim, S.M., Jung, M.P., Han, J., Sung, K.W., Kim, W.S., Jung, C.W., Yoon, S.S., Im, Y., Kang, W.K., Park, K., Park, C.H.> ;Am J Hematol. 2002 Oct
Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer.
Kim, K., Nam, E., Lee, N.S., Lee, H.R., Lee, J.Y., Lee, H.R., Park, S.H., Oh, S.Y., Kim, J.H., Song, S.Y., Park, J.O., Kim, W.S., Jung, C.W., Im, Y., Lee, M.H., Lee, W...> ;Am J Clin Oncol. 2002 Aug
Characterization of adult human prostatic epithelial-cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin-defective sv40-genome.
Lee M, Garkovenko E, Yun J, Weijerman P, Peehl D, Chen L, Rhim J> ;Int. J. Oncol.. 1994-04-01
Primary pulmonary non-Hodgkin''s lymphoma.
Kim, J. H., Lee, S. H., Park, J., Kim, H. Y., Lee, S. I., Park, J. O., Kim, K., Kim, W. S., Jung, C. W., Park, Y. S., Im, Y. H., Kang, W. K., Lee, M. H., Park, K., Han...> ;Jpn J Clin Oncol. 2004 Sep
Three cases of synchronous solid tumor and multiple myeloma.
Ji, S. H., Park, J. O., Lee, J., Oh, M. J., Lim, d. o. . H., Park, B. B., Park, K. W., Lee, S. H., Kim, K., Kim, W. S., Jung, C. W., Park, Y. S., Im, Y. H., Kang, W. ...> ;Cancer Res Treat. 2004 Oct
Join now to see all